Arcus Biosciences (RCUS) PT Raised to $29 at Barclays
Tweet
Share
E-mailGet Alerts RCUS Hot Sheet
Price: $30.34 +2.78%
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays analyst Peter Lawson raised the price target on Arcus Biosciences (NYSE: RCUS) to $29.00 (from $25.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- SentinelOne Inc (S) PT Raised to $22 at JPMorgan
- Flux Power Holdings (FLUX) PT Lowered to $1.60 at Roth/MKM
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
